177 related articles for article (PubMed ID: 11149430)
1. Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by bolus followed by infusion.
Fisher DM; Dempsey GA; Atherton DP; Brown R; Abengochea A; Hunter JM
Anesthesiology; 2000 Dec; 93(6):1384-91. PubMed ID: 11149430
[TBL] [Abstract][Full Text] [Related]
2. Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide.
Szenohradszky J; Caldwell JE; Wright PM; Brown R; Lau M; Luks AM; Fisher DM
Anesthesiology; 1999 Jan; 90(1):24-35. PubMed ID: 9915309
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting the pharmacokinetic characteristics of rapacuronium.
Fisher DM; Kahwaji R; Bevan D; Bikhazi G; Fragen RJ; Angst MS; Ornstein E; Matteo RS
Anesthesiology; 1999 Apr; 90(4):993-1000. PubMed ID: 10201669
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
Wight WJ; Wright PM
Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrhosis.
Duvaldestin P; Slavov V; Rebufat Y
Anesthesiology; 1999 Nov; 91(5):1305-10. PubMed ID: 10551581
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of rapacuronium in infants and children with intravenous and intramuscular administration.
Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
Anesthesiology; 2000 Feb; 92(2):376-86. PubMed ID: 10691223
[TBL] [Abstract][Full Text] [Related]
7. Rapacuronium recovery characteristics and infusion requirements during inhalation versus propofol-based anaesthesia.
Fu W; Klein KW; White PF; Chiu JW; Lemmens HJ; Whalley DG; Drover DR; Greenberg CP
Br J Anaesth; 2000 Aug; 85(2):302-5. PubMed ID: 10992842
[TBL] [Abstract][Full Text] [Related]
8. Newer neuromuscular blocking agents: how do they compare with established agents?
Sparr HJ; Beaufort TM; Fuchs-Buder T
Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
[TBL] [Abstract][Full Text] [Related]
9. Dose-response and onset/offset characteristics of rapacuronium.
Kopman AF; Klewicka MM; Ghori K; Flores F; Neuman GG
Anesthesiology; 2000 Oct; 93(4):1017-21. PubMed ID: 11020757
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular rapacuronium in infants and children: dose-ranging and tracheal intubating conditions.
Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
Anesthesiology; 1999 Nov; 91(5):1285-92. PubMed ID: 10551578
[TBL] [Abstract][Full Text] [Related]
11. Early reversal of rapacuronium with neostigmine.
Purdy R; Bevan DR; Donati F; Lichtor JL
Anesthesiology; 1999 Jul; 91(1):51-7. PubMed ID: 10422928
[TBL] [Abstract][Full Text] [Related]
12. A multicenter evaluation of the time-course of action of two doses of rapacuronium after early and late reversal with neostigmine.
Larijani GE; Donati F; Bikhazi G; Bartkowski R; Kenaan CA; Plaud B; Goldberg ME
Anesth Analg; 2001 Aug; 93(2):370-4 , 3rd contents page. PubMed ID: 11473863
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
[TBL] [Abstract][Full Text] [Related]
14. Rapacuronium bromide: a review of its use in anaesthetic practice.
Onrust SV; Foster RH
Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488).
Schiere S; Proost JH; Schuringa M; Wierda JM
Anesth Analg; 1999 Mar; 88(3):640-7. PubMed ID: 10072020
[TBL] [Abstract][Full Text] [Related]
16. The potency (ED50) and cardiovascular effects of rapacuronium (Org 9487) during narcotic-nitrous oxide-propofol anesthesia in neonates, infants, and children.
Kaplan RF; Fletcher JE; Hannallah RS; Bui DT; Slaven JS; Darrow EJ; Tsai KT
Anesth Analg; 1999 Nov; 89(5):1172-6. PubMed ID: 10553829
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
Hayes A; Breslin D; Reid J; Mirakhur RK
Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous recovery profile of rapacuronium during desflurane, sevoflurane, or propofol anesthesia for outpatient laparoscopy.
Zhou TJ; Coloma M; White PF; Tang J; Webb T; Forestner JE; Greilich NB; Duffy LL
Anesth Analg; 2000 Sep; 91(3):596-600. PubMed ID: 10960383
[TBL] [Abstract][Full Text] [Related]
19. A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide.
Wright PM; Brown R; Lau M; Fisher DM
Anesthesiology; 1999 Jan; 90(1):16-23. PubMed ID: 9915308
[TBL] [Abstract][Full Text] [Related]
20. Reversal of rapacuronium block during propofol versus sevoflurane anesthesia.
Zhou TJ; Tang J; White PF; Joshi GP; Wender R; Murphy MT; Chiu JW; Webb T
Anesth Analg; 2000 Mar; 90(3):689-93. PubMed ID: 10702458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
